A detailed history of Hoyle Cohen, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hoyle Cohen, LLC holds 16,279 shares of BMY stock, worth $947,926. This represents 0.05% of its overall portfolio holdings.

Number of Shares
16,279
Previous 16,078 1.25%
Holding current value
$947,926
Previous $871,000 22.39%
% of portfolio
0.05%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$40.25 - $52.99 $8,090 - $10,650
201 Added 1.25%
16,279 $676,000
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $3.43 Million - $3.88 Million
-71,387 Reduced 81.62%
16,078 $871,000
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $988,798 - $1.18 Million
-20,396 Reduced 18.91%
87,465 $4.49 Million
Q3 2023

Nov 02, 2023

BUY
$57.89 - $64.73 $57,716 - $64,535
997 Added 0.93%
107,861 $6.26 Million
Q2 2023

Aug 07, 2023

SELL
$63.71 - $70.74 $37,397 - $41,524
-587 Reduced 0.55%
106,864 $6.83 Million
Q1 2023

May 05, 2023

SELL
$65.71 - $74.53 $7,425 - $8,421
-113 Reduced 0.11%
107,451 $7.45 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $49,511 - $58,628
-723 Reduced 0.67%
107,564 $7.74 Million
Q3 2022

Nov 02, 2022

SELL
$0.13 - $76.84 $199 - $117,718
-1,532 Reduced 1.4%
108,287 $7.7 Million
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $96,802 - $106,613
-1,333 Reduced 1.2%
109,819 $8.46 Million
Q1 2022

May 03, 2022

SELL
$61.48 - $73.72 $51,151 - $61,335
-832 Reduced 0.74%
111,152 $8.12 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $139,867 - $163,052
-2,608 Reduced 2.28%
111,984 $6.98 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $42,010 - $49,210
710 Added 0.62%
114,592 $6.78 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $13,682 - $14,899
221 Added 0.19%
113,882 $7.61 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $3 Million - $3.37 Million
50,521 Added 80.01%
113,661 $7.18 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $43,478 - $49,268
-753 Reduced 1.18%
63,140 $3.92 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $42,555 - $47,157
-741 Reduced 1.15%
63,893 $3.85 Million
Q2 2020

Jul 29, 2020

BUY
$54.82 - $64.09 $87,383 - $102,159
1,594 Added 2.53%
64,634 $3.8 Million
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $27,747 - $40,323
598 Added 0.96%
63,040 $3.51 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $1.78 Million - $2.32 Million
36,181 Added 137.77%
62,442 $4.01 Million
Q3 2019

Nov 15, 2019

BUY
$42.77 - $50.71 $117,189 - $138,945
2,740 Added 11.65%
26,261 $1.33 Million
Q2 2019

Aug 09, 2019

BUY
$44.62 - $49.34 $190,348 - $210,484
4,266 Added 22.16%
23,521 $1.07 Million
Q1 2019

May 13, 2019

BUY
$45.12 - $53.8 $120,876 - $144,130
2,679 Added 16.16%
19,255 $919,000
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $53,733 - $69,679
-1,102 Reduced 6.23%
16,576 $862,000
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $54,969 - $62,001
-996 Reduced 5.33%
17,678 $1.1 Million
Q2 2018

Aug 06, 2018

SELL
$50.53 - $62.98 $61,747 - $76,961
-1,222 Reduced 6.14%
18,674 $1.03 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $30,139 - $34,696
503 Added 2.59%
19,896 $1.26 Million
Q4 2017

Feb 15, 2018

BUY
$59.94 - $65.35 $1.16 Million - $1.27 Million
19,393
19,393 $1.19 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hoyle Cohen, LLC Portfolio

Follow Hoyle Cohen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoyle Cohen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hoyle Cohen, LLC with notifications on news.